Resectable pancreatic adenocarcinoma: role of CT quantitative imaging biomarkers for predicting pathology and patient outcomes
Highlights • CT quantitative biomarkers can be helpful in the management of patients with pancreatic cancer. • Tumor attenuation measured at portal phase is associated with pathologic aggressiveness. • Texture and attenuation analysis can predict tumors associated with a worse prognosis. • CT quanti...
Gespeichert in:
| Veröffentlicht in: | European journal of radiology 2017-05, Vol.90, p.152-158 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 158 |
|---|---|
| container_issue | |
| container_start_page | 152 |
| container_title | European journal of radiology |
| container_volume | 90 |
| creator | Christophe, Cassinotto Chong, Jaron Zogopoulos, George Reinhold, Caroline Chiche, Laurence Lafourcade, Jean-Pierre Cuggia, Adeline Terrebonne, Eric Dohan, Anthony Gallix, Benoît |
| description | Highlights • CT quantitative biomarkers can be helpful in the management of patients with pancreatic cancer. • Tumor attenuation measured at portal phase is associated with pathologic aggressiveness. • Texture and attenuation analysis can predict tumors associated with a worse prognosis. • CT quantitative imaging biomarkers can improve the management of patients. |
| doi_str_mv | 10.1016/j.ejrad.2017.02.033 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1906470980</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0720048X17300785</els_id><sourcerecordid>1906470980</sourcerecordid><originalsourceid>FETCH-LOGICAL-c414t-28cb227aabfc46d5681a37fe80400932a3bbca1ef707eddee7d2e81a4d8f6b003</originalsourceid><addsrcrecordid>eNqFkc-L1TAQx4so7nP1LxAkRy_tTpK-Jk9QWB7-WFgQdAVvIU2mz3TbppukC-_i327qWz148RSG-XwzzGeK4iWFigJtLvoK-6BtxYCKClgFnD8qNlQKVgrBxONiA4JBCbX8flY8i7EHgG29Y0-LMya3kjdMbIqfXzCiSbodkMx6MgF1coZoi5M3Ohg3-VG_IcHnvu_I_obcLXpKLmXsHokb9cFNB9K6jIVbDJF0PpA5oHUmrZ1Zpx9-8Icj0ZNdK4dTIn5Jxo8YnxdPOj1EfPHwnhffPry_2X8qrz9_vNpfXpempnUqmTQtY0LrtjN1Y7eNpJqLDiXUADvONG9boyl2AgRaiygsw8zUVnZNC8DPi9enf-fg7xaMSY0uGhwGPaFfoqI7aGoBO7mi_ISa4GMM2Kk55DXDUVFQq3jVq9_i1SpeAVNZfE69ehiwtCPav5k_pjPw9gRgXvPeYVDRZBUmiwr5AMp6958B7_7Jm8FNzujhFo8Ye7-EKRtUVMUcUF_X26-np4IDCLnlvwDoA628</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1906470980</pqid></control><display><type>article</type><title>Resectable pancreatic adenocarcinoma: role of CT quantitative imaging biomarkers for predicting pathology and patient outcomes</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Christophe, Cassinotto ; Chong, Jaron ; Zogopoulos, George ; Reinhold, Caroline ; Chiche, Laurence ; Lafourcade, Jean-Pierre ; Cuggia, Adeline ; Terrebonne, Eric ; Dohan, Anthony ; Gallix, Benoît</creator><creatorcontrib>Christophe, Cassinotto ; Chong, Jaron ; Zogopoulos, George ; Reinhold, Caroline ; Chiche, Laurence ; Lafourcade, Jean-Pierre ; Cuggia, Adeline ; Terrebonne, Eric ; Dohan, Anthony ; Gallix, Benoît</creatorcontrib><description>Highlights • CT quantitative biomarkers can be helpful in the management of patients with pancreatic cancer. • Tumor attenuation measured at portal phase is associated with pathologic aggressiveness. • Texture and attenuation analysis can predict tumors associated with a worse prognosis. • CT quantitative imaging biomarkers can improve the management of patients.</description><identifier>ISSN: 0720-048X</identifier><identifier>EISSN: 1872-7727</identifier><identifier>DOI: 10.1016/j.ejrad.2017.02.033</identifier><identifier>PMID: 28583627</identifier><language>eng</language><publisher>Ireland: Elsevier B.V</publisher><subject>Adenocarcinoma - pathology ; Adult ; Aged ; Biomarkers ; Cancer staging ; Carcinoma, Pancreatic Ductal - diagnostic imaging ; Carcinoma, Pancreatic Ductal - pathology ; CT attenuation value ; Disease-Free Survival ; Female ; Humans ; Lymph Nodes - pathology ; Male ; Middle Aged ; Multidetector Computed Tomography - methods ; Neoplasm Recurrence, Local - diagnostic imaging ; Neoplasm Recurrence, Local - pathology ; Pancreatic adenocarcinoma prognosis ; Pancreatic Neoplasms - diagnostic imaging ; Pancreatic Neoplasms - pathology ; Prognosis ; Quantitative imaging biomarkers ; Radiology ; Retrospective Studies ; Texture analysis</subject><ispartof>European journal of radiology, 2017-05, Vol.90, p.152-158</ispartof><rights>Elsevier B.V.</rights><rights>2017 Elsevier B.V.</rights><rights>Copyright © 2017 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c414t-28cb227aabfc46d5681a37fe80400932a3bbca1ef707eddee7d2e81a4d8f6b003</citedby><cites>FETCH-LOGICAL-c414t-28cb227aabfc46d5681a37fe80400932a3bbca1ef707eddee7d2e81a4d8f6b003</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0720048X17300785$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28583627$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Christophe, Cassinotto</creatorcontrib><creatorcontrib>Chong, Jaron</creatorcontrib><creatorcontrib>Zogopoulos, George</creatorcontrib><creatorcontrib>Reinhold, Caroline</creatorcontrib><creatorcontrib>Chiche, Laurence</creatorcontrib><creatorcontrib>Lafourcade, Jean-Pierre</creatorcontrib><creatorcontrib>Cuggia, Adeline</creatorcontrib><creatorcontrib>Terrebonne, Eric</creatorcontrib><creatorcontrib>Dohan, Anthony</creatorcontrib><creatorcontrib>Gallix, Benoît</creatorcontrib><title>Resectable pancreatic adenocarcinoma: role of CT quantitative imaging biomarkers for predicting pathology and patient outcomes</title><title>European journal of radiology</title><addtitle>Eur J Radiol</addtitle><description>Highlights • CT quantitative biomarkers can be helpful in the management of patients with pancreatic cancer. • Tumor attenuation measured at portal phase is associated with pathologic aggressiveness. • Texture and attenuation analysis can predict tumors associated with a worse prognosis. • CT quantitative imaging biomarkers can improve the management of patients.</description><subject>Adenocarcinoma - pathology</subject><subject>Adult</subject><subject>Aged</subject><subject>Biomarkers</subject><subject>Cancer staging</subject><subject>Carcinoma, Pancreatic Ductal - diagnostic imaging</subject><subject>Carcinoma, Pancreatic Ductal - pathology</subject><subject>CT attenuation value</subject><subject>Disease-Free Survival</subject><subject>Female</subject><subject>Humans</subject><subject>Lymph Nodes - pathology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Multidetector Computed Tomography - methods</subject><subject>Neoplasm Recurrence, Local - diagnostic imaging</subject><subject>Neoplasm Recurrence, Local - pathology</subject><subject>Pancreatic adenocarcinoma prognosis</subject><subject>Pancreatic Neoplasms - diagnostic imaging</subject><subject>Pancreatic Neoplasms - pathology</subject><subject>Prognosis</subject><subject>Quantitative imaging biomarkers</subject><subject>Radiology</subject><subject>Retrospective Studies</subject><subject>Texture analysis</subject><issn>0720-048X</issn><issn>1872-7727</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc-L1TAQx4so7nP1LxAkRy_tTpK-Jk9QWB7-WFgQdAVvIU2mz3TbppukC-_i327qWz148RSG-XwzzGeK4iWFigJtLvoK-6BtxYCKClgFnD8qNlQKVgrBxONiA4JBCbX8flY8i7EHgG29Y0-LMya3kjdMbIqfXzCiSbodkMx6MgF1coZoi5M3Ohg3-VG_IcHnvu_I_obcLXpKLmXsHokb9cFNB9K6jIVbDJF0PpA5oHUmrZ1Zpx9-8Icj0ZNdK4dTIn5Jxo8YnxdPOj1EfPHwnhffPry_2X8qrz9_vNpfXpempnUqmTQtY0LrtjN1Y7eNpJqLDiXUADvONG9boyl2AgRaiygsw8zUVnZNC8DPi9enf-fg7xaMSY0uGhwGPaFfoqI7aGoBO7mi_ISa4GMM2Kk55DXDUVFQq3jVq9_i1SpeAVNZfE69ehiwtCPav5k_pjPw9gRgXvPeYVDRZBUmiwr5AMp6958B7_7Jm8FNzujhFo8Ye7-EKRtUVMUcUF_X26-np4IDCLnlvwDoA628</recordid><startdate>20170501</startdate><enddate>20170501</enddate><creator>Christophe, Cassinotto</creator><creator>Chong, Jaron</creator><creator>Zogopoulos, George</creator><creator>Reinhold, Caroline</creator><creator>Chiche, Laurence</creator><creator>Lafourcade, Jean-Pierre</creator><creator>Cuggia, Adeline</creator><creator>Terrebonne, Eric</creator><creator>Dohan, Anthony</creator><creator>Gallix, Benoît</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20170501</creationdate><title>Resectable pancreatic adenocarcinoma: role of CT quantitative imaging biomarkers for predicting pathology and patient outcomes</title><author>Christophe, Cassinotto ; Chong, Jaron ; Zogopoulos, George ; Reinhold, Caroline ; Chiche, Laurence ; Lafourcade, Jean-Pierre ; Cuggia, Adeline ; Terrebonne, Eric ; Dohan, Anthony ; Gallix, Benoît</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c414t-28cb227aabfc46d5681a37fe80400932a3bbca1ef707eddee7d2e81a4d8f6b003</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adenocarcinoma - pathology</topic><topic>Adult</topic><topic>Aged</topic><topic>Biomarkers</topic><topic>Cancer staging</topic><topic>Carcinoma, Pancreatic Ductal - diagnostic imaging</topic><topic>Carcinoma, Pancreatic Ductal - pathology</topic><topic>CT attenuation value</topic><topic>Disease-Free Survival</topic><topic>Female</topic><topic>Humans</topic><topic>Lymph Nodes - pathology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Multidetector Computed Tomography - methods</topic><topic>Neoplasm Recurrence, Local - diagnostic imaging</topic><topic>Neoplasm Recurrence, Local - pathology</topic><topic>Pancreatic adenocarcinoma prognosis</topic><topic>Pancreatic Neoplasms - diagnostic imaging</topic><topic>Pancreatic Neoplasms - pathology</topic><topic>Prognosis</topic><topic>Quantitative imaging biomarkers</topic><topic>Radiology</topic><topic>Retrospective Studies</topic><topic>Texture analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Christophe, Cassinotto</creatorcontrib><creatorcontrib>Chong, Jaron</creatorcontrib><creatorcontrib>Zogopoulos, George</creatorcontrib><creatorcontrib>Reinhold, Caroline</creatorcontrib><creatorcontrib>Chiche, Laurence</creatorcontrib><creatorcontrib>Lafourcade, Jean-Pierre</creatorcontrib><creatorcontrib>Cuggia, Adeline</creatorcontrib><creatorcontrib>Terrebonne, Eric</creatorcontrib><creatorcontrib>Dohan, Anthony</creatorcontrib><creatorcontrib>Gallix, Benoît</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of radiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Christophe, Cassinotto</au><au>Chong, Jaron</au><au>Zogopoulos, George</au><au>Reinhold, Caroline</au><au>Chiche, Laurence</au><au>Lafourcade, Jean-Pierre</au><au>Cuggia, Adeline</au><au>Terrebonne, Eric</au><au>Dohan, Anthony</au><au>Gallix, Benoît</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Resectable pancreatic adenocarcinoma: role of CT quantitative imaging biomarkers for predicting pathology and patient outcomes</atitle><jtitle>European journal of radiology</jtitle><addtitle>Eur J Radiol</addtitle><date>2017-05-01</date><risdate>2017</risdate><volume>90</volume><spage>152</spage><epage>158</epage><pages>152-158</pages><issn>0720-048X</issn><eissn>1872-7727</eissn><abstract>Highlights • CT quantitative biomarkers can be helpful in the management of patients with pancreatic cancer. • Tumor attenuation measured at portal phase is associated with pathologic aggressiveness. • Texture and attenuation analysis can predict tumors associated with a worse prognosis. • CT quantitative imaging biomarkers can improve the management of patients.</abstract><cop>Ireland</cop><pub>Elsevier B.V</pub><pmid>28583627</pmid><doi>10.1016/j.ejrad.2017.02.033</doi><tpages>7</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0720-048X |
| ispartof | European journal of radiology, 2017-05, Vol.90, p.152-158 |
| issn | 0720-048X 1872-7727 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1906470980 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Adenocarcinoma - pathology Adult Aged Biomarkers Cancer staging Carcinoma, Pancreatic Ductal - diagnostic imaging Carcinoma, Pancreatic Ductal - pathology CT attenuation value Disease-Free Survival Female Humans Lymph Nodes - pathology Male Middle Aged Multidetector Computed Tomography - methods Neoplasm Recurrence, Local - diagnostic imaging Neoplasm Recurrence, Local - pathology Pancreatic adenocarcinoma prognosis Pancreatic Neoplasms - diagnostic imaging Pancreatic Neoplasms - pathology Prognosis Quantitative imaging biomarkers Radiology Retrospective Studies Texture analysis |
| title | Resectable pancreatic adenocarcinoma: role of CT quantitative imaging biomarkers for predicting pathology and patient outcomes |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T18%3A32%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Resectable%20pancreatic%20adenocarcinoma:%20role%20of%20CT%20quantitative%20imaging%20biomarkers%20for%20predicting%20pathology%20and%20patient%20outcomes&rft.jtitle=European%20journal%20of%20radiology&rft.au=Christophe,%20Cassinotto&rft.date=2017-05-01&rft.volume=90&rft.spage=152&rft.epage=158&rft.pages=152-158&rft.issn=0720-048X&rft.eissn=1872-7727&rft_id=info:doi/10.1016/j.ejrad.2017.02.033&rft_dat=%3Cproquest_cross%3E1906470980%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1906470980&rft_id=info:pmid/28583627&rft_els_id=S0720048X17300785&rfr_iscdi=true |